[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 11, 1985

False Hope on Drug Availability-Reply

Author Affiliations

Englewood Hospital Englewood, NJ
Ohio University Athens
School of Public Health Columbia University New York

JAMA. 1985;254(14):1905. doi:10.1001/jama.1985.03360140057023

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In Reply.—  It was certainly not our intention to raise false hope for anyone concerned with the treatment of postherpetic neuralgia, specifically pertaining to the availability of AMP for use. Our article was clearly placed in the category of PRELIMINARY COMMUNICATION, the results reported were clearly investigational clinical trials, and no recommendations for immediate and widespread use of AMP were made. Drug availability, information on supplies, and trade names of products are not commonly included in this type of a communication, although we can sympathize with patients seeking immediate relief from their neuralgia even from the drug still undergoing investigational trials.With any new or investigational agent being evaluated for human use, drug safety and therapeutic effectiveness will have to be documented before widespread administration can be warranted.

×